Strimed Pharmaceuticals Private Limited
About Strimed Pharmaceuticals Private Limited
Data last updated:
Strimed Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 24 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2018PTC305544.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹13 Lakh. It is led by directors Raghunandan Nilkantrao Kadam and Deepak Bhimrao Kawalkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101. Khushi Apartment 2 Near Thakur Vidyalay Moreggaon Nalasopora (East) Mumbai, Maharashtra, India – 401209.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.47 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹5.14 Lakh (net margin 3.5%) and EBITDA of ₹7.07 Lakh (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 25% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address101. Khushi Apartment 2 Near Thakur Vidyalay Moreggaon Nalasopora (East) Mumbai, Maharashtra, India – 401209
- IndustryChemicals, Manufacturing, Other Chemical Product, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Strimed Pharmaceuticals Private Limited
The main business activity of Strimed Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Strimed Pharmaceuticals Private Limited FY 2025 filings available
Strimed Pharmaceuticals Private Limited reported revenue of ₹1.47 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Strimed Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 13% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Strimed Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.07 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.14 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Strimed Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Strimed Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Strimed Pharmaceuticals Private Limited
Strimed Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hawitt Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Rajasthan, India |
| Cure World Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Panchkula, Haryana, India |
| Exorrent Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Saharsa, Bihar, India |
| Bazio Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Hyderabad, Telangana, India |
| Isocratic Pharmaceuticals Private Limited | ₹1.47 Cr (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Strimed Pharmaceuticals Private Limited this company | ₹1.47 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Sthree Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | •••• | •••• | -69.0% | •••• | Chennai, Tamil Nadu, India |
| Jagbir Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2023) | •••• | •••• | 221.0% | •••• | Rohtak, Haryana, India |
| Stevia Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Secunderabad, Telangana, India |
| Helisinki Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Karnal, Haryana, India |
| Azeudus Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2022) | •••• | •••• | 128.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Strimed Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Strimed Pharmaceuticals Private Limited
Strimed Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghunandan Nilkantrao Kadam | Director | 24 Feb 2018 | 8 Years 7 Months | Current |
| Deepak Bhimrao Kawalkar | Director | 24 Feb 2018 | 8 Years 7 Months | Current |
Charges & Borrowings of Strimed Pharmaceuticals Private Limited
Strimed Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Strimed Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Strimed Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Strimed Pharmaceuticals Private Limited
Strimed Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Deepak Bhimrao Kawalkar was appointed as Director on 24 Feb 2018.
Credit Ratings, Litigation & Regulatory Alerts for Strimed Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Strimed Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Strimed Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Strimed Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Strimed Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strimed Pharmaceuticals Private Limited
Strimed Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 24 February 2018 (8+ years old) and is registered under CIN U24299MH2018PTC305544.
Strimed Pharmaceuticals reported revenue of ₹1.47 Cr for FY 2025 (up 13% YoY).
Strimed Pharmaceuticals has 2 current directors:
- Raghunandan Nilkantrao Kadam - Director
- Deepak Bhimrao Kawalkar - Director
Strimed Pharmaceuticals reported a net profit of ₹5.14 Lakh (net margin 3.5%) and EBITDA of ₹7.07 Lakh (EBITDA margin 4.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Strimed Pharmaceuticals is 26% over three years and 25% over five years. In the latest year (FY 2025) revenue rose 13%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Strimed Pharmaceuticals is U24299MH2018PTC305544. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Strimed Pharmaceuticals was incorporated on 24 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Strimed Pharmaceuticals by revenue are Hawitt Pharmaceuticals Private Limited, Cure World Pharmaceuticals Private Limited, Exorrent Pharmaceuticals Private Limited, Bazio Pharmaceuticals Private Limited, Isocratic Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Deepak Bhimrao Kawalkar was appointed as Director on 24 Feb 2018. Raghunandan Nilkantrao Kadam was appointed as Director on 24 Feb 2018.
The registered office of Strimed Pharmaceuticals is at 101. Khushi Apartment 2 Near Thakur Vidyalay Moreggaon Nalasopora East Mumbai, Maharashtra, India – 401209.
Strimed Pharmaceuticals has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹13 Lakh.